Showing 41-50 of 352 grants
| Title | Institution | Researcher | Program | Duration | Total Award Amount |
|---|---|---|---|---|---|
| Thermally responsive minimally invasive proangiogenic placeholder for cell transplantation for Type 1 Diabetes | University of Washington | Patrick Stayton | Cures | 01-November-2025 to 31-October-2028 | $894.965,96 |
| METabolic MODulation to Enhance Insulin Sensitivity and Mitochondrial Function in Type 1 Diabetes (MetMod-T1D) | University of Washington | Petter Bjornstad | Improving Lives | 01-September-2025 to 31-August-2028 | $2.040.014,30 |
| microRNAs as regulators of stem cell differentiation into islet cells | University of Washington | Vincenzino Cirulli | Cures | 01-August-2025 to 31-July-2027 | $600.000,00 |
| Promoting functional maturation of SC-derived beta-cells by novel Epigenetic regulators | University of Washington | Vincenzino Cirulli | Cures | 01-October-2024 to 30-September-2026 | $500.000,00 |
| Structural approaches to understand biased insulin signaling and design glucose-binding proteins for smart insulin therapeutics | University of Utah | Amber Vogel | Improving Lives | 01-March-2024 to 28-February-2027 | $228.995,00 |
| Optimization of fast-acting venom insulins as therapeutic candidates for T1D | University of Utah | Helena Safavi | Improving Lives | 01-September-2022 to 31-August-2026 | $890.372,53 |
| Can Addition of Pioglitazone to SGLT2 Inhibitor in Type 1 Diabetic Patients Amplify the Decrease in HbA1c and Mitigate Diabetic Ketoacidosis Risk? | University of Texas Health Science Center at San Antonio | Muhammad Abdul-Ghani | Improving Lives | 01-June-2019 to 31-December-2026 | $1.573.835,31 |
| Dock2-mediated T cell migration as a targetable shared mechanism in autoimmunity | University of Pittsburgh | Alok Joglekar | Cures | 01-September-2025 to 28-February-2027 | $149.999,05 |
| Engineered Regulatory T cells for Suppression of Type 1 Diabetes | University of Pittsburgh | Alok Joglekar | Cures | 01-August-2026 to 31-July-2028 | $187.584,10 |
| New approach for tolerance induction after allogeneic islets transplantation | University of Pittsburgh | Eric Lagasse | Cures | 01-September-2026 to 31-August-2027 | $249.994,05 |